Telix Pharmaceuticals Limited
← Back to TLX Overview

Telix Pharmaceuticals Limited (TLX)

Solvency & Capital Structure

Total Debt

$784.5M

Net Debt

$571.9M

Telix Pharmaceuticals Limited currently has $784.5M in total debt. Net debt is $571.9M after cash offsets.

Financial Fundamentals

TLXQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2025-12-310.780.210.571.7744.3%
2025-06-300.420.210.211.1935.1%
2024-12-310.580.71-0.13Net Cash1.5238.3%
2024-06-300.020.12-0.10Net Cash0.753.0%
2023-12-310.020.12-0.11Net Cash0.404.4%
2023-06-300.010.13-0.12Net Cash0.314.2%
2022-12-310.010.12-0.11Net Cash0.264.0%
2022-06-300.000.12-0.12Net Cash0.221.2%
2021-12-310.000.02-0.02Net Cash0.112.3%
2021-06-300.000.05-0.05Net Cash0.131.3%
2020-12-310.000.08-0.08Net Cash0.161.3%
2020-06-300.000.02-0.02Net Cash0.103.1%
2019-12-310.000.04-0.04Net Cash0.102.1%
2019-06-300.000.01-0.01Net Cash0.072.8%
2018-12-310.000.03-0.02Net Cash0.082.3%
2018-06-300.000.04-0.04Net Cash0.050.8%
2017-12-310.000.05-0.05Net Cash0.050.7%
2017-06-300.000.01-0.01Net Cash0.010.0%
2000-09-300.000.00-0.00Net Cash0.010.0%